编辑:严格的方法很重要:重新评估怀孕中乙氨基的安全性
1Melbourne Medical School, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Australia.
Journal of the American Academy of Child and Adolescent Psychiatry
|November 27, 2025
概括
在怀孕期间使用乙氨基是常见的,可能与儿童的神经发育风险有关. 本系统性审查和元分析研究了这一关键关联.
科学领域:
- 产科和妇科 产科和妇科
- 儿科神经学 儿科神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙氨基 (类) 被孕妇广泛使用,高达70%的人报告使用.
- 像美国FDA这样的监管机构正在调查产前乙氨基暴露与神经发育不良结果之间的潜在联系.
- 了解在怀孕期间使用乙氨基的安全性具有重大公共卫生和科学利益.
研究的目的:
- 系统地审查和元分析现有证据,以证明在怀孕期间使用乙胺和后代的神经发育结果之间的关联.
- 提供关于这个主题的当前科学文献的全面评估.
主要方法:
- 进行了相关研究的系统审查.
- 进行了元分析,以综合多项研究的发现.
- 评估了包含的研究的质量和设计.
主要成果:
- 综述和元分析评估了母亲服用乙氨基和儿童神经发育之间的关系.
- 评估了与产前暴露有关的特定神经发育结果.
- 这些发现有助于了解怀孕期间使用乙氨基的潜在风险.
结论:
- 该研究提供了关于产前乙氨基暴露和后代神经发育之间的复杂关系的关键见解.
- 结果为临床实践和公共卫生建议提供了关于在怀孕期间使用乙氨基的信息.
- 进一步的研究可能是有必要的,以充分阐明观察到的关联.
更多相关视频
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...


